Psychedelic startup makes a deal with Big Pharma

Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets

Terran Biosciences, a private psychedelic startup, announced a licensing deal with the French Big Pharma company Sanofi (SNY). Terran will license two of Sanofi’s pipeline assets that target central nervous system (CNS) disorders. The assets have generated more than 100 clinical studies involving 15,000 subjects on a variety of CNS disorders.

PDF of article